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Background: After right lobe donation, biliary complication is the main cause of morbidity. Mortality after
right lobe donation has been estimated to be less than 0.5%.
Patients and methods: Between November 2001 and December 2008, 207 adult-to-adult living donor
liver transplantations (ALDLT) were undertaken using right lobe grafts. Donors included 173 men and 34
women with a mean age of 28.4  5.2 years.
Results: Siblings comprised 144 (69.6%) cases whereas unrelated donors comprised 63 (30.4%) with a
mean body mass index (BMI) of 25.2  2.4. Single and multiple right hepatic ducts (RHD) were present
in 82 (39.6%) and 125 (60.3%) donors, respectively. Mean operative time was 360  50 min with an
estimated blood loss of 950  450 ml and returned cell-saver amount of 450  334 ml. Mean donor
remnant liver volume was 33.5  3.2%. Mean intensive care unit (ICU) stay was 3  0.7 days and mean
hospital stay was 14  3.5 days. Modified Clavien classifications were used to stratify all donor biliary
complications The overall biliary complications occurred in 27 cases (13.0%). After modified Clavien
classification, biliary complications were graded as grade I (n = 10), grade II (n = 2), grade III (n = 14) and
grade V (n = 1). Grade I and II (n = 12) biliary complications were successfully managed conservatively.
Grade III cases were treated using ultrasound-guided aspiration (USGA), endoscopic retrograde cholan-
giography (ERCP) and surgery in 10, 2 and 2 donors, respectively. Single donor mortality (Grade V) (0.4%)
occurred after uncontrolled biliary leakage with peritonitis that necessitated exploration followed by ERCP
with stent insertion but the donor died on day 43 as a result of ongoing sepsis.
Conclusion: Although the majority of biliary complications are minor and can be managed conserva-
tively, uncontrolled biliary leakage is a serious morbidity that should be avoided as it could lead to
mortality.
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Introduction
Since 2001, adult-to-adult living donor liver transplantation
(ALDLT) has been the only available treatment with curative
intent for patients with end-stage liver disease (ESLD) in Egypt.1,2
There is an absence of a deceased donor transplant programme as
a result of the ongoing debate around brain stem death and the
issuing of a comprehensive transparent organ transplant law. The
concerns that patients have only one chance with an equivalent
graft and patient survivals together with the challenges of donor
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risk adds to the complexity of the situation. Biliary anomalies are
more common in right liver (RLG) compared with left liver grafts
(LLG).3,4 Large stature Egyptian patients almost always impose the
need for RLG harvesting compared with the Far East where LLG
are often used.5,6 Biliary complications are the main cause of mor-
bidity after right-sided donation.7 Unresolved biliary complica-
tions may lead to sepsis, multi-organ failure (MOF) and death.
Mortality after right lobe donation has been estimated to be less
than 0.5%. This report documents biliary complications including
a single mortality in the first 207 RLG living donors.
Patients and methods
Study population
From November 2001 to December 2008, 207 ALDLT procedures
were undertaken for patients with ESLD and/or hepatocellular
carcinoma (HCC). RLG were harvested, in all donors, either with
(n = 30) or without (n = 177) the middle hepatic vein (MHV).
Demographic data of the study population included 173 males
and 34 females with s age range between 18 and 50 years. The
mean age of all donors was 28.4  5.2 years. Only donors with a
maximum body mass index (BMI)  28 was accepted and
assessed for donation. The mean BMI was 25.2  2. Accepted
criteria of live donation were met within a family member in 144
(69.6%) donors whereas the remaining 63 (30.4%) cases could
not identify a reasonable sibling for donation and received a RLG
from an unrelated friend. The three-steps donor preparation pro-
tocol has been reported elsewhere.2 Liver biopsy is a routine prac-
tice in donor preparation and macrovesicular steatosis is only
accepted if it is between 0 and 15% with the total absence of any
portal inflammation.
Psychosocial assessment by an experienced informed psychiatrist
is an integral step in donor preparation to exclude any coercion
and ensure altruism.
Informed consent was obtained from all donors after making
sure that they fully understood the procedure details, possible
risks and complications as well as all the short-term post-
operative financial implications resulting from a period of sick
leave of the order of 6–8 weeks.
Ethics
The hospital ethical committee has to review all patient and donor
files and meet with either the donor or recipient before approving
donation. A separate donor advocate team was instituted recently
and has started to revise donor assessment and defend all donor
rights of being fully informed at all times.
Operative technique
The detailed operative technique for RLG harvesting without
inclusion of the MHV has been described elsewhere.2 The Hong
Kong technique8 of harvesting RLG with MHV was adopted
whenever the decision was to proceed with this technique (n = 30).
All procedures were done and/or supervised by one of the first two
authors. The technique of tackling the right hepatic duct (RHDs)
included: routine intra-operative cholangiogram, keeping peri-
ductal dissection to the minimum followed by sharp transection
of RHDs before starting parenchymal transection. The hilar plate
is divided and suture ligated using 5/0 prolene on both sides.
RHDs stumps, kept at 2–3 mm from the junction between
common hepatic duct (CHD) and left hepatic duct (LHD), are
closed by interrupted 6/0 PDS. Biliary leakage from the closed
stump or from the transection margin is tested twice by saline
injection into the cystic duct catheter immediately after stump
closure and after graft harvesting. Routine conclusion cholangio-
gram to visualize the left biliary system and document absence
of any leakage or ductal stenosis is the last step in the donor
operation.
Cell saver (Dedico, Electa; Sorin group, Mirandola, Italy) is
routinely used in all donor operations. Prophylaxis against throm-
boembolism is offered to all donors when the prothrombin
concentration reaches 50% and kept for 4 weeks on a single sub-
cutaneous (s.c.) daily dose of enoxparine 40 mg /day.
In an effort to decrease the incidence of biliary complication,
bilirubin content in drain effluent is routinely measured, if any
doubt exists until bilirubin content is less than the serum bilirubin
level. Minor bile leaks are monitored carefully as this usually
settles spontaneously; however, if it becomes symptomatic by
clinical and/or laboratory measures, an abdominal CT scan
and/or MRC is immediately done. Having the full data of a given
donor, an elaborate discussion is made between the experienced
surgeon, endoscopist and an interventional radiologist aiming at
reaching a consensus decision on what would be the appropriate
intervention whether ultrasound-guided aspiration, endoscopic
retrograde cholangiography (ERCP), percutaneous transhepatic
dilatation (PTD) or surgery. Cases treated by ultrasound-guided
aspiration and insertion of a pig-tail catheter were followed by
abdominal ultrasound. The decision to remove the pig-tail was
taken when the draining amount was less than 50 ml/day for 2
successive days with abdominal ultrasound documenting com-
plete disappearance of any abdominal collection.
Follow-up plan
After discharge, all donors are followed at the out-patient clinic
every week for 1 month to ensure a normal liver profile and to
assess a comparative CT volumetry by a senior surgeon. Thereaf-
ter, donors are seen once every month or every 3 months for 2
years according to the presence or not of biliary complications.
Donors are informed to return if they have any complaints or
abnormalities at any point during the whole follow-up period.
Statistical analysis
Categorical variables were expressed as frequencies and
percentages. Continuous data were expressed as mean (SD).
To study the impact of the number of the right bile ducts on
the incidence of biliary complications, Fisher’s exact test was
used. SPSS v. 15.0 for Windows (SPSS, Inc., Chicago, IL, USA) was
used for data analysis.
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Results
The mean operative time was 360  50 min with a mean blood
loss of 950 450 ml. No autologus or allogenic blood is prepared
for live liver donors. The mean amount of cell saver blood was 443
 334 ml. Two cases (0.9%) were re-operated for bleeding and
received two units of allogenic packed red blood cells (RBCs)
each.
Graft data
The donor mean total liver volume was 1324.3  187.1 g. The
mean graft-recipient body weight ratio (GRWR) was 1.1  0.3%
whereas the mean donor remnant liver volume (RLV) was 473.8
97.5 g which was equivalent to 34.5  3.2% of the donor’s total
liver volume. Single and multiple RHD were present in 82 (39.6%)
and 125 (60.3%) donors, respectively. Multiple RHD included 2
or 3 RHD in 116 (56%) and 9 (4.3%) cases, respectively.
Hospital stay
The mean intensive care unit (ICU) stay was 3 0.7 days whereas
the mean hospital stay was 13.5 3.3 days. The follow-up period
ranged from 3 to 86 months with a mean of 46  4.3 months.
Donor complications: were graded according to the modified
Clavien classification9 of surgical complications. In the whole
study population, the overall complications was 28.5% (n = 59)
with biliary complications alone constituting 13.0% (27 cases).
All types of donor complications after Clavien classification are
shown in Fig. 1.
Biliary complications (Table 1): Twenty-seven donors (13.04%)
suffered biliary complications. Within these 27 donors, the RHD
was single in 12 (14%) and multiple in 15 (12%) being double in
14 and triple in a single donor (P = 0.72). Biliary complications
were separately graded, according to modified Clavien classifica-
tion,9,10 as grade I (n = 10, 37%), grade II (n = 2, 0.07%), grade III
(n = 14, 51%), grade IV (n = 0) and grade V (n = 1). Grade III were
sub-divided into grade III a (n = 10) and grade III b (n = 4). The
10 cases that fell within grade I included minor biliary leaks and
prolonged drainage time than usual with resultant prolonged hos-
pitalization. Two grade II donors received additional antibiotic
therapy after finishing the protocol-based prophylactic regimen in
response to fever and rigours and guided by the draining effluent
culture and sensitivity.
Grade III a/b biliary complications
The 14 grade III donors had biliary leaks in 13 cases and biliary
stricture in a single case (Fig. 2). This group was further divided
according to the type of management into grade III a (n = 10) and
grade III b (n = 4).
Ten grade IIIa donors had symptomatic sub-phrenic biliary
collection of different sizes and all 10 donors within this grade
were managed successfully using ultrasound-guided aspiration
and pig-tail tube drainage. The draining tube was left for a period
that ranged from 1 to 3 weeks and then removed without any
further intervention.
Grade IIIb donor complications were managed by ERCP and
surgery in two patients, respectively. Prolonged sub-phrenic
biliary collections that did not resolve by USGA in two patients
was dealt with successfully by ERCP and insertion of a 10-F stent.
Surgical management was resorted to in two donors; one by
T-tube insertion after failure of ERCP to control the leak. After 1
month, a normal control cholangiogram was followed by removal
of the T-tube. Two months later, an elevated total bilirubin and
mild intra-hepatic biliary dilatation prompted ERCP and stent







Figure 1 Donor complications according to the modified Clavien
classification
Table 1 Biliary complications according to the modified Clavien classification
Grade of complication Biliary complication Treatment Outcome
Grade I (n = 10) Minor biliary leak; prolonged drainage time/ hospitalization No Alive
Grade II (n = 2) Mild controlled sepsis Antibiotics Alive
Grade III a (Local anaesthesia) (n = 10) Symptomatic sub-phrenic collection USGA. Alive
Grade III b (General anaesthesia) (n = 4) Prolonged sub-phrenic collection
– Excessive bile leak, failure of ERCP
– Accidental CHD transaction
ERCP (n = 2)
Surgery (n = 2)
Alive
Grade IV (n = 0) – – –
Grade V (n = 1) Uncontrolled bile leak, uncontrolled sepsis Surgery/ERCP Death
Total: n = 27 (13.04%) 27 (13.04%)
USGA, ultrasound guided aspiration; CHD, common hepatic duct; ERCP, endoscopic retrograde cholangio pancreatography.
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insertion to deal with a stricture at the LHD and CHD junction. A
second patient that required surgery underwent LHD to CHD
anastomosis over a 6-F biliary stent after accidental CHD transec-
tion during the index donor operation. The biliary stent was
removed after 1 month but anastomotic stricture occurred 2
month later and was managed by PTD and stent insertion. Three
months later, ERCP and stent replacement was performed but the
stent was removed after another 3 months and has remained stent
free. All grade III b donors are alive and back to their normal life
and activities.
Grade V biliary complication
A single donor mortality (0.4%) occurred. This was donor
number 32 who was a 44-year-old male with a BMI of 28 and was
donating to his brother, with no documented co-morbidity and a
liver biopsy that revealed 5% steatosis. The donor surgery was
uneventful and lasted 330 min with 630 ml blood loss and a single
RHD stump that was closed with 6/0 PDS in a continuous fashion.
Total liver volume was 1340 g and the RLV was 480 g (35.8%). A
biliary leak was declared on post-operative day 5 and was thought
to be well drained but the patient developed biliary peritonitis
necessitating exploration on day 11. The RHD stump was found
to be the source of leakage. Peritoneal toilet and closure of the
leaking site by interrupted PDS 6/0 was performed followed by
draining all abdominal compartments. The patient did well for 10
days but then became more septic when biliary leak recurred and
increased such that re-exploration on day 31 was undertaken. The
abdominal cavity was found to be clean and the site of leakage was
well drained by the remaining drains. Full left liver regeneration
had occurred precluding easy access to the leaking site. The
ongoing bile leak led to the decision to perform ERCP on day 38,
in a an attempt to seal the leaking site. Repeat cultures from all
body fluids and appropriate antibiotic therapy was continued
through the post-operative course. However, the donor suc-
cumbed on day 43 as a result of uncontrolled sepsis and multi-
organ failure. An autopsy was not done as this practice, although
extremely useful, is rejected by our community. This case was
reviewed in detail by the local ethical committee and the trans-
plant team who were asked to hold the programme for one month
and revise all steps included in the protocol including pre-
operative, operative and post-operative measures.
Outcome
There were no deaths reported above and during a follow-up
period that ranged between 3 and 84 months, all 26 donors who
have had biliary complications are alive, and have gone back to
their usual activities and are pursuing a normal life.
Discussion
ALDLT has gained popularity during the past decade because
of the widening gap between the demand and supply of liver grafts
from deceased donors in the West. The particular situation in
Egypt has left little choice for ESLD patients and the transplant
community but to accept LDLT. However, the fact remains that a
substantial number of patients cannot identify a family member
as an acceptable donor because of blood group incompatibility,
age restriction, obesity or lack of the motivation to donate. In the
present study, this group represented one-third of the study po-
pulation (30.4%). We are aware of all the implications that this
practice entails in a country where an organ transplant law has not
yet seen the light. Making sure that every donor is fully aware of all
likely operative and post-operative events and clearly informed by
the unit’s own results is regularly revised11–13 A local ethical com-
mittee has had the responsibility of approving each case with its
donor by setting realistic reasonable standards to ensure complete
awareness of the donor and family about the procedure and docu-
ment lack of coercion. Routine liver biopsy is practiced for two
reasons; first, the high levels of obesity and steatotic livers and
second, the bilharzial heritage although it is now fair to regard it as
a vanishing problem.
Since the first successful ALDLT,14 RLG has been regarded as the
optimal graft for ESLD adult patients in terms of size, function
and accommodation of the frequently high portal flow.15
Although the feasibility of LLG in, small-sized, adult patients has
been elegantly demonstrated,6,16 we were unable to replicate this
practice in our adult patients as the pre-operative volume calcu-
lation coupled with the frequent steatotic livers in Egypt almost
always precluded LLG as an option for our adult patients. RLG
represented the minimal requirement to cope with the metabolic
needs, advanced disease status and severe portal hypertension in
big stature Egyptian patients. After gaining enough experience,
donors with dominant middle hepatic vein, who were refused
before, started to be accepted by the end of 2006 where 30 RLG
with MHV inclusion8 have been done without reporting any mor-
bidity in these donors.
In a systematic review including 131 studies, Middleton et al.
reported donor morbidity ranging from zero to 100% with a
median of 16.1%.17 We are documenting an overall complication
rate around 28.5%, 15% of which is non-biliary complications.
The wide discrepancy in reported figures of complications could
be explained by while some reports are concerned with severe may









Figure 2 Grade III biliary complications
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be life-threatening complications18 others mention all types of
complications even the most trivial ones.19,20 While the extent of
liver segment donation, the learning curve effect and the observa-
tion period are important factors in this respect, the lack of a
standardized universally accepted scale for documenting live liver
donor complications is an important factor in the wide variation
of reported complication rates. In the present study, we applied
the modified Clavien classification9 referring each and every com-
plication to this classification with a total complication rate of
28.5%. Shah et al.21 adopted the same principle, using the original
Clavien classification of surgical complications,10 and recorded an
overall complication rate of 37%. Recently, Chan et al.22 according
to modified Clavien classification,9 considered that the accepted
overall morbidity rate in ALDLT should stay around 20%.
Right liver lobe anomalies, especially biliary anomalies, are
common with the presence of multiple biliary orifices being a
problem almost specific to RLG.4,23 Biliary complications are the
most common morbidity in living liver donors constituting some
0–38.6% with a median of 6.2%.17 A low biliary complication rate
of 2.4–5.3% has been reported after harvesting all types of liver
grafts, right and left, together.7,24 Considering biliary complica-
tions according to the type of the harvested graft, RLG donation
yielded a higher biliary complication rate ranging from 10 to 12%
compared with that after LLG donation which ranged from 2 to
4%.16,24 In the current study, we had a slightly higher biliary com-
plications rate of 13.4% mainly biliary leaks with a single case
of biliary stricture. Minor biliary complications occurred in 12
(44.4%) out of the total 27 cases that had biliary complications,
Clavien grade I or II, and needed no interventions at all. However,
14 cases (51.8%) were classified as Clavien grade III necessitating
radiological/endoscopic intervention in 12 and surgical correction
in 2 cases. Bile leak from the resection margin occurs in 5–10% of
RLG donors.25,26 All Clavien grade I, II and III A cases were biliary
leaks of varying degree accounting for 81.4% (n = 22) of the total
biliary complications in the current study. Considering the whole
study population, this is equivalent to a 10.6% bile leak rate which
is consistent with other reported studies.
Pre-operative donor evaluation and selection could be partly
responsible for the more serious Clavien grade III B biliary com-
plications. Sixty per cent of the presented donor population had
multiple RHDs, a finding that is not commonly shared by other
studies.3,4 Considering that multiple, rather than single, RHDs
might be a risk factor for donor biliary complications was not
valid in this study as within the 27 donors who developed biliary
complications 12 (14%) had single whereas 15 (12%) had more
than one RHD yielding a non-significant difference between the
two groups. Therefore, pre-operative identification of multiple
RHDs was not rejected if the donor is proved to be otherwise fit
for donation in all other aspects. This strategy could be further
justified appreciating that the process of identifying a reasonable
living liver donor has been always a painful task for the family.
Anatomically, excessive dissection of the right hepatic artery
from behind the CHD could be responsible for some ischaemic
effect resulting in increased bile leakage or stenosis following
RLG compared to LLG harvesting.16 Operatively, we transect the
RHD(s) after operative cholangiography, full dissection of the
right hepatic pedicle and before commencing parenchymal
transection. We believe that this puts the left biliary system out of
harms way and by suture ligation of the divided hilar plate on
both sides, parenchymal transection is made more safe, rapid and
easier. Alternatively, RHD division is performed by others either
after transection of the anterior two-third21,27 or at the conclusion
of parenchymal transaction28 with similar rates of biliary com-
plications. Thus, the best timing of RHD division remains to be
settled.
The majorty of biliary complications is managed by conser-
vative or minimally invasive procedures such as USGA.29 We
managed 81.2% (n = 22) of our biliary complications successfully
in a similar manner. Nevertheless, Clavien grade IIIB donors (n =
4) underwent major manipulation of their left bile duct system by
ERCP in two cases and surgical correction in two cases. The latter
two donors needed further management by PTD and ERCP with
ballon dilatation and stent insertion in more than one setting.
During donor surgery, iatrogenic biliary injury is one of the most
dreadful complications. CHD was transected instead of RHD once
in donor 137 that we can’t reside on the learning curve effect as a
reason for this type of complication. Meanwhile, the remaining
three donors with grade IIIB complications occurred early on
during the second and third year of the whole study period reflect-
ing the learning curve effect. Although complete recovery was
established in all four donors, the course has been long, worrying
and temporary affected the donor moral. Major manipulation of
the biliary system by PTD from above or ERCP from below is
usual practice in recipients but is at least alarming
in healthy donors. Lee et al. followed a similar strategy with an
equivalent outcome.29 To date, all Clavien grade IIIB donors are
pursuing their life normally without recurrence during a mean
follow-up period of 46 months.
Death of a healthy live donor is torturing to the responsible
transplant team and the medical community at large. Regrettably,
worldwide recorded live liver donor mortality is not regularly
followed or updated to include all continents. This regretful event
happened in 0.2–0.5% in most reported series.11,30 After RLG
donation, 0.5% mortality is the circulating figure.11 This report
documents a single donor mortality in a large series of 207
ALDLT, equivalent to 0.4%, as a result of ongoing uncontrolled
sepsis with MOF stemming from major uncontrolled biliary leak.
Identifying pre-operative or operative risk factors that could be
responsible for RHD stump bile leak, in this case, was not possible
except that we assumed that RHD stump closure in a continuous
fashion should be replaced by an interrupted manner although
there is no data to support this assumption. A standard protocol
of dealing with early biliary complications, involving all expertise,
has been followed since the occurrence of our tragic event.
In conclusion, in an effort of continuous documentation the
current study is reporting on the most common morbidity after
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live donation in ALDLT. Biliary complications are serious events
in the post-operative setting as they may lead to mortality and
therefore should be avoided by all means. Every aspect including
donor selection, pre-operative preparation, operative technique
and post-operative care, should be regularly revised and discussed
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